Biocodex secures rights to Batten-1 and TX01 in agreement worth up to €173 million THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex ...
GENTILLY, France--(BUSINESS WIRE)--THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance ...
GENTILLY, France, February 10, 2026--(BUSINESS WIRE)--THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing ...
Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...
SANTA ANA — Few expected Mater Dei would be clinging to a one-point lead at the half against Kahuku, which travelled 2,500 miles from Honolulu to take on the top-ranked team in the nation. Even fewer ...
The NBA offseason is arguably more exciting than the regular season. There's player free agency, the NBA Draft, summer league, trades ... the list goes on. High school football offseason in Southern ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results